Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor

Author： Bannwarth Bernard   Berenbaum Francis  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.4, 2005-04, pp. : 521-533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacology of Lumiracoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Rordorf Christiane M.  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1247-1266

Adis International

Access to resources Recommend Favorite

Clinical pharmacology of celecoxib, a COX-2 selective inhibitor

By Antoniou Katerina   Malamas Michael   Drosos Alexandros A  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1719-1732

Informa Healthcare

Access to resources Recommend Favorite

Selective cyclooxygenase-2 inhibitors: pharmacology, clinical effects and therapeutic potential

By Ryn J.v.   Pairet M.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 5, 1997-05 ,pp. : 609-614

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Davies N.M.  

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite

Clinical pharmacology of etoricoxib: a novel selectiveCOX2 inhibitor

By Patrignani Paola   Capone Marta L   Tacconelli Stefania  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 2, 2003-02 ,pp. : 265-284

Informa Healthcare

Access to resources Recommend Favorite